Control Pricing, Incentives, and Revenue Execution in Complex, Regulated Markets
Enterprise software designed to govern pricing, incentives, contracts, and gross to net processes for pharmaceutical and biotech companies operating in highly regulated, multi channel markets.
Challenge
Pharmaceutical and biotech organizations operate some of the most complex commercial models in any industry. Pricing, rebates, chargebacks, fees, and discounts vary by contract, channel, payer, and geography, while compliance and reporting requirements continue to increase. Many teams still rely on spreadsheets and fragmented systems to manage these programs, creating risk, delays, and limited visibility into true net revenue.
As products launch, portfolios expand, and access models evolve, organizations struggle to enforce contract terms, manage gross to net exposure, and respond quickly to market and regulatory change. Without a controlled execution layer, complexity increases faster than the ability to manage it.
IMA360 is the system of control for pharmaceutical and biotech commercial execution. It centralizes pricing rules, contracts, incentives, and gross to net processes in a governed platform, ensuring decisions are executed consistently and transparently across channels and partners. By replacing spreadsheet driven processes with automated workflows and validation, IMA360 helps life sciences organizations scale complexity without increasing risk.
for Pharmaceuticals & Biotech
Solutions for Pharmaceuticals & Biotech
Distributor Chargeback
Distributor chargeback software to reconcile pricing differences across indirect channels
Capabilities
Built to support regulated environments and complex access models, IMA360 provides the control and transparency required across the pharmaceutical and biotech value chain.
Results
With governed execution and real time visibility, pharmaceutical and biotech organizations gain confidence in revenue, compliance, and decision making.